CellR4 2019; 7: e2788
DOI: 10.32113/cellr4_201911_2788

Islet Transplantation in the UK

Johnson P. R. V.
Director of the Oxford DRWF Islet Isolation Facility, Director of the Islet Transplant Programme, and Chair of the NHSBT UK Islet Steering Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, Oxford, UK
paul.johnson@nds.ox.ac.uk
, UK Islet Transplant Consortium (UKITC) On behalf of the

Topic: Islet transplantation   Category:

Abstract

This commentary outlines the development and current status of the UK Islet Transplant Programme in the UK. The author makes the case that it is now time for similar fully funded beta-cell programmes to be made available in many other countries as well.

Free PDF Download

To cite this article

Johnson P. R. V.
Director of the Oxford DRWF Islet Isolation Facility, Director of the Islet Transplant Programme, and Chair of the NHSBT UK Islet Steering Group, Nuffield Department of Surgical Sciences, University of Oxford, Oxford Centre for Diabetes, Endocrinology, and Metabolism, Churchill Hospital, Oxford, UK
paul.johnson@nds.ox.ac.uk
, UK Islet Transplant Consortium (UKITC) On behalf of the
Islet Transplantation in the UK

CellR4 2019; 7: e2788
DOI: 10.32113/cellr4_201911_2788

Publication History

Submission date: 31 Oct 2019

Revised on: 04 Nov 2019

Accepted on: 08 Nov 2019

Published online: 08 Nov 2019